Study of a new heart valve for severe pulmonary valve leakage
Part of Heart & circulation clinical trials.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Weigh at least 55 pounds (25 kg)
- Be 12 years old or older
- Have severe backward leakage of blood through your pulmonary valve (without significant narrowing)
- Be willing to come back for all follow-up visits after the procedure
- Not have an active heart infection, blood clotting disorder, or other major condition making the procedure risky
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of replacement valve for children who need a new pulmonary valve (the valve between the heart and lungs). Researchers want to see if the valve works safely and well in real-world use.
This observational study follows people who need a pulmonary valve treatment, to see how the Venus P-Valve works in real-world care. It may help doctors understand which patients benefit and how outcomes change over time.
This study looks at a new device called the PULSTA Transcatheter Pulmonary Valve, which is placed without open-heart surgery to help people with a leaky or narrowed pulmonary valve. It aims to see how well the valve works over time.
This study tests whether a new type of heart valve made from your own tissue (an “autologous” valve) can be placed through a catheter safely in adults with leaking and pressure-related problems in the lung heart valve area. If it works well, it could offer a safer option for people who need treatment for pulmonary valve problems.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
This study tests a new device called the Vesalius TMVr system to fix a leaky mitral valve without open-heart surgery. It's for people with severe mitral regurgitation who are not good candidates for surgery.
Hear when a new Pulmonary Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.